It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Many intracellular bacteria, including Chlamydia, establish a parasitic membrane-bound organelle inside the host cell that is essential for the bacteria’s survival. Chlamydia trachomatis forms inclusions that are decorated with poorly characterized membrane proteins known as Incs. The prototypical Inc, called IncA, enhances Chlamydia pathogenicity by promoting the homotypic fusion of inclusions and shares structural and functional similarity to eukaryotic SNAREs. Here, we present the atomic structure of the cytoplasmic domain of IncA, which reveals a non-canonical four-helix bundle. Structure-based mutagenesis, molecular dynamics simulation, and functional cellular assays identify an intramolecular clamp that is essential for IncA-mediated homotypic membrane fusion during infection.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Thomas Jefferson University, Department of Biochemistry and Molecular Biology, Philadelphia, PA, USA; Institute of Biomembranes and Bioenergetics, National Research Council, Bari, Italy
2 Thomas Jefferson University, Department of Microbiology and Immunology, Philadelphia, PA, USA; Janssen Research and Development, Spring House, PA, USA
3 Thomas Jefferson University, Department of Microbiology and Immunology, Philadelphia, PA, USA
4 The University of Delaware, Department of Chemistry and Biochemistry, Newark, DE, USA
5 Thomas Jefferson University, Department of Biochemistry and Molecular Biology, Philadelphia, PA, USA
6 Thomas Jefferson University, Department of Microbiology and Immunology, Philadelphia, PA, USA; VUE Health, Boston, MA, USA